About You Holding Valuation
Is 0A9O undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0A9O when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0A9O (€3.36) is trading below our estimate of fair value (€19.07)
Significantly Below Fair Value: 0A9O is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0A9O?
Key metric: As 0A9O is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0A9O's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | €1.96b |
| Market Cap | €564.67m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.3x |
| Enterprise Value/EBITDA | -9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0A9O's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.3x | ||
ASC ASOS | 0.2x | 3.1% | UK£440.9m |
BOO boohoo group | 0.3x | 3.2% | UK£393.6m |
BWNG N Brown Group | 0.3x | 0.6% | UK£171.4m |
SHOE Shoe Zone | 0.4x | 0.9% | UK£69.3m |
0A9O About You Holding | 0.3x | 7.7% | €564.7m |
Price-To-Sales vs Peers: 0A9O is expensive based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.3x).
Price to Sales Ratio vs Industry
How does 0A9O's PS Ratio compare vs other companies in the GB Specialty Retail Industry?
Price-To-Sales vs Industry: 0A9O is good value based on its Price-To-Sales Ratio (0.3x) compared to the UK Specialty Retail industry average (0.3x).
Price to Sales Ratio vs Fair Ratio
What is 0A9O's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | 0.5x |
Price-To-Sales vs Fair Ratio: 0A9O is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €3.36 | €5.29 +57.7% | 23.9% | €7.00 | €3.20 | n/a | 10 |
| Nov ’25 | €3.15 | €5.26 +67.0% | 24.9% | €7.00 | €3.10 | n/a | 10 |
| Oct ’25 | €3.23 | €5.24 +62.5% | 24.8% | €7.00 | €3.10 | n/a | 10 |
| Sep ’25 | €3.10 | €5.34 +72.5% | 24.6% | €7.00 | €3.10 | n/a | 10 |
| Aug ’25 | €3.56 | €5.34 +50.2% | 24.6% | €7.00 | €3.10 | n/a | 10 |
| Jul ’25 | €3.21 | €5.64 +76.0% | 20.0% | €7.50 | €3.60 | n/a | 10 |
| Jun ’25 | €3.85 | €5.64 +46.5% | 20.0% | €7.50 | €3.60 | n/a | 10 |
| May ’25 | €4.51 | €5.81 +29.0% | 20.8% | €7.50 | €3.60 | n/a | 10 |
| Apr ’25 | €4.30 | €5.77 +34.3% | 20.1% | €7.50 | €3.60 | n/a | 11 |
| Mar ’25 | €4.16 | €5.68 +36.6% | 20.7% | €7.50 | €3.60 | n/a | 11 |
| Feb ’25 | €4.05 | €5.68 +40.1% | 20.7% | €7.50 | €3.60 | n/a | 11 |
| Jan ’25 | €4.36 | €5.92 +35.8% | 18.4% | €8.00 | €4.10 | n/a | 11 |
| Dec ’24 | €4.37 | €5.92 +35.5% | 18.4% | €8.00 | €4.10 | n/a | 11 |
| Nov ’24 | €4.01 | €6.06 +51.2% | 18.5% | €8.00 | €4.10 | €3.15 | 11 |
| Oct ’24 | €5.39 | €6.26 +16.1% | 19.8% | €8.00 | €4.10 | €3.23 | 11 |
| Sep ’24 | €6.27 | €6.30 +0.4% | 20.2% | €8.30 | €4.10 | €3.10 | 11 |
| Aug ’24 | €6.43 | €6.25 -2.7% | 19.5% | €8.30 | €4.10 | €3.56 | 11 |
| Jul ’24 | €4.69 | €6.25 +33.3% | 25.0% | €9.50 | €4.10 | €3.21 | 11 |
| Jun ’24 | €4.56 | €6.34 +39.0% | 23.2% | €9.50 | €4.30 | €3.85 | 11 |
| May ’24 | €5.61 | €7.52 +34.0% | 39.5% | €15.00 | €4.50 | €4.51 | 11 |
| Apr ’24 | €5.03 | €7.72 +53.3% | 38.5% | €15.00 | €4.70 | €4.30 | 11 |
| Mar ’24 | €5.23 | €7.89 +50.9% | 38.9% | €15.00 | €4.70 | €4.16 | 10 |
| Feb ’24 | €6.07 | €7.85 +29.4% | 38.9% | €15.00 | €4.70 | €4.05 | 10 |
| Jan ’24 | €5.87 | €8.69 +48.0% | 44.9% | €18.00 | €5.00 | €4.36 | 10 |
| Dec ’23 | €6.15 | €8.68 +41.1% | 45.1% | €18.00 | €4.90 | €4.37 | 10 |
| Nov ’23 | €5.42 | €8.48 +56.4% | 44.6% | €18.00 | €4.90 | €4.01 | 10 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Abercrombie & Fitch
US$7.9b
Through its subsidiaries, operates as an omnichannel retailer in the United States, Europe, the Middle East, Asia, the Asia-Pacific, Canada, and internationally.
0R32
US$148.58
7D
5.0%
1Y
92.3%
Frasers Group
UK£3.2b
Frasers Group Plc, together with its subsidiaries, retails sports and leisure clothing, footwear, homeware, furniture, sports equipment and bicycles, accessories, and apparel through department stores, shops, and online in the United Kingdom, Europe, the United States, Asia, Oceania, and internationally.
FRAS
UK£7.50
7D
0.07%
1Y
-15.1%
Alibaba Group Holding
US$194.6b
Through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses to engage with their users and customers in the People's Republic of China and internationally.
AHLAD
US$81.40
7D
-1.5%
1Y
16.4%